Xencor share price logo

Xencor

NASDAQ: XNCR

Small Cap

$27.80

+0.80

(+2.96%)

as on

Xencor Stock Performance

as on August 22, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $27.07
    $28.16
    downward going graph

    2.63%

    Downside

    1.29%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.13
    $23.45
    downward going graph

    74.35%

    Downside

    -15.65%

    Upside

    downward going graph

Xencor share price movements today

Previous Close
$27.00
Open
$27.37
Volume
646.7K
Market Cap
$1.7B
Day's Low - High
$27.07 - $28.16
52 Week Low - High
$7.13 - $23.45

Xencor Historical Returns

1 Month Return
+ 33.6 %
3 Month Return
+ 108.02 %
1 Year Return
+ 203.91 %
3 Year Return
+ 4.1 %
5 Year Return
-28.07 %

Xencor Stock Fundamentals & Key Indicators

Check Xencor market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

-3.1138

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-205.9M

Revenue (TTM)

105.0M

Profit Margin

-155.59%

Return On Equity TTM

-29.07%

Xencor vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xencor with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.7B-28.07%NA-155.59%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Xencor Stock including INR - Dollar returns

The Xencor stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xencor investment value today

Current value as on today

₹3,96,709

Returns

₹2,96,709

(+296.71%)

Returns from Xencor Stock

₹2,61,979 (+261.98%)

Dollar Impact

₹34,730 (+34.73%)

Analyst Recommendation on Xencor Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Xencor. Average target price of $29

Xencor Share Price Target

Get share price movements and forecasts by analysts on Xencor.

What analysts predicted

4.14%UPSIDE

Target Price

$29

Current Price

$27.8

Analyzed by

10 Analysts

Target

$29.00

Xencor target price $29, a slight upside of 4.14% compared to current price of $27.8. According to 10 analysts rating.

Indian Investors' Interest in Xencor Stock

Search interest for Xencor Stock has increased by 346% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:346% versus previous 30 day period

Xencor Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
15
16
17
70
32
43
20
28
4
51
Gross Profit
-40
13
-40
70
30
40
-33
25
1
51
Operating Income
-54
-62
-55
4
-43
-33
-47
-53
-77
-37
EBITDA
-61
-63
-35
-15
-36
-20
4
5
-121
-12
Interest Expense
9
0
0
33
8
8
7
7
4
7
Depreciation
3
3
3
2
2
2
2
2
2
2
Income Before Tax
-74
-67
-47
-52
-48
-31
-6
-4
-128
-21
Income Tax Expense
0
0
-1
1
0
0
-
2
0
0
Net Income
-73
-65
-46
-53
-48
-30
-6
-6
-128
-21
Net Profit Margin
-459.09%
-388.93%
-260.10%
-76.38%
-147.92%
-70.69%
-28.70%
-23.56%
-2854.65%
-42.42%

Xencor Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
87
35
40
156
122
275
164
168
110
125
Gross Profit
87
35
40
38
122
275
164
-85
-117
115
Operating Income
22
-53
-79
13
-76
43
-82
-138
-178
-177
EBITDA
24
-51
-76
18
-71
51
-73
-125
-186
-46
Interest Expense
0
0
0
17
-
7
36
6
36
31
Depreciation
-
2
3
4
5
7
8
10
12
10
Income Before Tax
24
-49
-70
27
-69
82
-54
-120
-234
-89
Income Tax Expense
0
0
8
0
-5
-7
0
5
1
2
Net Income
23
-48
-70
26
-63
82
-55
-126
-232
-91
Net Profit Margin
26.99%
-137.00%
-173.41%
17.15%
-51.79%
30.04%
-33.53%
-74.90%
-210.53%
-73.20%

Xencor Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-68
-48
-54
-48
-30
-6
85
-128
-21
Operating Cash Flow
-67
-26
-55
-16
-36
-30
-51
-67
-55
Investing Cash Flow
66
-163
57
11
40
14
71
26
85
Financing Cash Flow
1
187
10
2
0
-
6
0
1
Change in Cash
0
-1
11
-1
4
-16
25
-40
30

Xencor Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-48
-70
26
-69
82
-55
-126
-236
-91
Operating Cash Flow
-33
-79
64
-5
-16
24
85
-202
-135
Investing Cash Flow
31
-164
-50
100
-46
-119
-
-7
139
Financing Cash Flow
3
254
10
18
43
5
26
197
8
Change in Cash
2
9
24
113
-20
-89
0
-12
13

Mutual Funds that own Xencor Stock

Check out the Mutual Funds with significant holdings in Xencor.

Funds
Holdings
Shares Held
PRIMECAP Odyssey Funds
12.850425%
9554727
VANGUARD INDEX FUNDS
5.837887%
4340667
Fidelity Salem Street Trust
1.068034%
794120
Fidelity Concord Street Trust
0.978629%
727644
T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.
0.859906%
639370

Global Institutional Holdings in Xencor

Funds
Holdings
Theofanis Kolokotrones
13.9%
iShares
11.84%
Peter Kolchinsky
6.59%
Vanguard
5.68%
SPDR
4.76%

Insights on Xencor

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -128.91M → -21.72M (in $), with an average increase of 493.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, XNCR stock has moved up by 145.8%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 4.51M → 51.22M (in $), with an average increase of 91.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 235.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 570.7% return, outperforming this stock by 548.6%

About Xencor

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. It also develops XmAb819, a bispecific antibody to treat renal cell carcinoma; XmAb541, which is in Phase I for the treatment of ovarian cancer; XmAb808, a bispecific antibody that binds to the broadly expressed tumor antigen; XmAb942, which is in clinical development for patients with Crohn's disease and ulcerative colitis; Plamotamab, a bispecific T-cell, which is in Phase Ib study to treat rheumatoid arthritis; and XmAb657 for patients with idiopathic inflammatory myopathies. Further, the company develops Xaluritamig, a bispecific T-cell engager that treats prostate cancer; ASP2138 to treat gastric, gastroesophageal junction, and pancreatic cancers; JNJ-9401 to treat metastatic castration-resistant prostate cancer; Obexelimab, an antibody to treat patients with autoimmune diseases; Tobevibart, a treatment for chronic hepatitis Delta; Zaltenibart to treat paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders; Teropavimab and zinlirvimab to treat human immunodeficiency virus; Novartis, an antibody drug candidate that uses XmAb Fc technologies; and JNJ-1493 to treat B-cell malignancies. The company was incorporated in 1997 and is headquartered in Pasadena, California.
OrganisationXencor
Headquarters465 North Halstead Street, Pasadena, CA, United States, 91107
IndustryBiotechnology
CEODr. Bassil I. Dahiyat Ph.D.
E-voting on sharesClick here to vote

Key Management of Xencor

Name

Title

Ms. Jennifer Sandoz

Senior VIce President of Human Resources

Mr. Dane Vincent Leone C.F.A.

Executive VP & Chief Strategy Officer

Dr. Mark Osterman M.D.

Senior Vice President of Clinical Development (Autoimmune)

Dr. John R. Desjarlais Ph.D.

Executive VP of Research & Chief Scientific Officer

Mr. Charles Liles

Associate Director and Head of Corporate Communications & Investor Relations

Ms. Celia E. Eckert J.D.

Senior VP, General Counsel & Corporate Secretary

Mr. Kirk Rosemark RAC

Senior Vice President of Regulatory Affairs & Quality Assurance

Mr. Eric P. Kowack

Senior Vice President of Program Leadership & Alliance Management

Dr. Bassil I. Dahiyat Ph.D.

Co-Founder, CEO, President & Director

Mr. Bart Jan Cornelissen

Senior VP & CFO

FAQs

What is Xencor share price today?

Xencor share price today is $27.80 as on at the close of the market. Xencor share today touched a day high of $28.16 and a low of $27.07.

What is the 52 week high and 52 week low for Xencor share?

Xencor share touched a 52 week high of $23.45 on and a 52 week low of $7.13 on . Xencor stock price today i.e. is closed at $27.80,which is -18.55% down from its 52 week high and 289.90% up from its 52 week low.

What is Xencor's market capitalisation today?

Xencor market capitalisation is $0.00T as on .

How to invest in Xencor Stock (XNCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xencor on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xencor Shares that will get you 0.0540 shares as per Xencor share price of $27.80 per share as on August 22, 2026 at 8:46 am IST.

What is the minimum amount required to buy Xencor Stock (XNCR) from India?

Indian investors can start investing in Xencor (XNCR) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in Xencor stock (as per the Rupee-Dollar exchange rate as on ). Based on Xencor share’s latest price of $27.80 as on August 22, 2026 at 8:46 am IST, you will get 0.3597 shares of Xencor. Learn more about fractional shares .

What are the returns that Xencor has given to Indian investors in the last 5 years?

Xencor stock has given -28.07% share price returns and 29.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?